Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Models of Health Promotion and Illness Prevention II01:18

Models of Health Promotion and Illness Prevention II

2.3K
The person's health status fluctuates continually, varying from being in good health to becoming ill and returning to being healthy. To understand the concept of illness prevention, there are two models. First, the health-illness continuum model is a graphic representation of an individual's wellness. It states that a person is considered healthy in the absence of physical disease and the presence of good emotional health.
The agent-host-environment model states that disease results...
2.3K
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

739
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
739
Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

373
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
373
Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

609
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
609
Nursing Interventions I: Taxonomy of Nursing Interventions01:03

Nursing Interventions I: Taxonomy of Nursing Interventions

4.4K
Nursing interventions are chosen as part of the planning process to achieve patient outcomes. Once nursing diagnoses are determined, the goals and outcomes are specified, then the nursing interventions are selected and individualized according to the patient's situation.
A nursing intervention is a treatment or action based on scientific concepts and knowledge from the nursing, behavioral, and physical sciences. Identifying and prioritizing nursing interventions based on the desired outcome...
4.4K
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

12.8K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
12.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Implications of regional variations in climate change vulnerability and mitigation behaviour for social-climate dynamics.

Nature communications·2026
Same author

When simple is enough: Binary models capture social complexity in coupled human-environment systems.

Mathematical biosciences·2026
Same author

Prejudice and objectivity, not social influence, determine long-term outcomes in coupled opinion-environment dynamics in polarized populations.

Journal of theoretical biology·2026
Same author

Homophily in a multi-group vaccination game and its impact on disease dynamics.

Proceedings. Biological sciences·2026
Same author

Forecasting infectious disease outbreak risks from vaccine sentiments on social media: A data-driven dynamical systems approach.

Mathematical biosciences and engineering : MBE·2025
Same author

"Early, rapid, aggressive": when strategic interactions between governments, opposition, and lobbies can hinder effective responses to epidemics.

Frontiers in epidemiology·2025

Related Experiment Video

Updated: Apr 11, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.8K

Disease Interventions Can Interfere with One Another through Disease-Behaviour Interactions.

Michael A Andrews1, Chris T Bauch2

  • 1Department of Mathematics and Statistics, University of Guelph, Guelph, Ontario, Canada.

Plos Computational Biology
|June 6, 2015
PubMed
Summary

Vaccination significantly reduces influenza incidence more than non-pharmaceutical interventions (NPIs) due to higher efficacy. Combining vaccination and NPIs is effective, but focusing solely on NPIs has minimal impact on disease spread.

More Related Videos

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

1.5K
Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways
06:43

Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways

Published on: January 13, 2016

9.5K

Related Experiment Videos

Last Updated: Apr 11, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.8K
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

1.5K
Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways
06:43

Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways

Published on: January 13, 2016

9.5K

Area of Science:

  • Epidemiology
  • Network Science
  • Behavioral Economics

Background:

  • Understanding infectious disease spread on networks is crucial.
  • Behavioral factors like vaccination and non-pharmaceutical interventions (NPIs) influence transmission.
  • Existing models often study these interventions separately.

Purpose of the Study:

  • To develop a simulation model of influenza transmission incorporating individual decision-making for vaccination and NPIs.
  • To analyze the interplay and interference between vaccination and NPIs.
  • To identify effective strategies for reducing influenza incidence.

Main Methods:

  • Constructed a simulation model of influenza transmission on a contact network.
  • Modeled individual decisions for vaccination and NPIs based on experience, contact's infection status, and personal/social impacts.
  • Analyzed intervention interference and impact on disease dynamics.

Main Results:

  • Vaccination and NPIs interfere, making simultaneous uptake challenging due to negative feedback loops.
  • Vaccine efficacy is higher than NPI efficacy, leading to greater reduction in influenza incidence with increased vaccination.
  • Expanding NPI practice alone has minimal impact, while expanding vaccination significantly reduces incidence.

Conclusions:

  • Intervention interference must be carefully considered in public health programs.
  • Strategies supporting vaccination, or both vaccination and NPIs, are most effective in reducing influenza.
  • Further research is needed on the combined impact of multiple interventions for various infectious diseases.